Drug Repurposing Agent
Identify new therapeutic applications for existing pharmaceuticals, dramatically reducing time-to-market and development costs.
Key Features
- Multi-modal data integration from clinical trials, scientific literature, and molecular databases
- Advanced machine learning algorithms to identify novel drug-disease associations
- Network-based analysis of protein-protein interactions and pathway involvement
- Predictive modeling of drug efficacy for new indications
- Evidence generation and prioritization of repurposing candidates
Business Benefits
- Reduce development costs by up to 85% compared to novel drug development
- Accelerate time-to-market from 10-15 years to 3-5 years
- Revitalize existing patent portfolios with new indications
- Minimize risk with compounds already proven safe in humans
- Generate evidence-backed regulatory documentation